Two broad areas of investigation will be examined in delineating the role of the vascular endothelium in the potential immunopathogenesis of vasculitis. Experimental models of endothelial cell function will be established with the idea of eventually using such models to study regulatory factors in vasculitis. The endothelial cell will be studied for its ability to modulate immune cell function in various ways, such as the ability of endothelial cells to serve as accessory cells for lymphocyte activation and the capacity of endothelial cells to produce immunoregulatory molecules such as interleukin-1. In particular, the regulation of IL-1 production by endothelium cells by immune and inflammatory mediators, as well as factors from vasculitic patient's sera and cells will be studied in depth. The expression of immunological cell surface markers by endothelial cells will also be studied and their relationship to and modulation by factors related to clinically active vasculitis. Endothelial cells will also be examined as a potential target for injury in vasculitis by concentrating on the potential antigenicity of endothelial cell plasma membrane proteins such as angiotensin-1-converting enzyme and lipoprotein lipase. The role of cell mediated immunity to endothelial cells and cell mediated immunity directed to basement membrane collagen will also be studied. These proposed experiments may shed new and exciting information on the potential immunopathogenesis of necrotizing vasculitis. A better understanding of the mechanism of vascular injury in vasculitis should lead to a more rational approach to the therapy of patients with this widely varied disorder.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL033961-02
Application #
3346405
Study Section
Pathology A Study Section (PTHA)
Project Start
1985-04-01
Project End
1987-03-31
Budget Start
1986-04-01
Budget End
1987-03-31
Support Year
2
Fiscal Year
1986
Total Cost
Indirect Cost
Name
Tufts University
Department
Type
Schools of Medicine
DUNS #
604483045
City
Boston
State
MA
Country
United States
Zip Code
02111
Borish, L; Rosenbaum, R; McDonald, B et al. (1990) Recombinant interleukin-1 beta interacts with high-affinity receptors to activate neutrophil leukotriene B4 synthesis. Inflammation 14:151-62
Gurka, G; Ohman Jr, J; Rosenwasser, L J (1989) Allergen-specific human T cell clones: derivation, specificity, and activation requirements. J Allergy Clin Immunol 83:945-54
Auron, P E; Warner, S J; Webb, A C et al. (1987) Studies on the molecular nature of human interleukin 1. J Immunol 138:1447-56
Webb, A C; Collins, K L; Snyder, S E et al. (1987) Human monocyte Arg-Serpin cDNA. Sequence, chromosomal assignment, and homology to plasminogen activator-inhibitor. J Exp Med 166:77-94
Rosenwasser, L J; Webb, A C; Clark, B D et al. (1986) Expression of biologically active human interleukin 1 subpeptides by transfected simian COS cells. Proc Natl Acad Sci U S A 83:5243-6